10th Jul 2014 08:05
RNS Number : 9141L
Skyepharma PLC
10 July 2014
Skyepharma PLC ("Company")
Director declaration
In accordance with Listing Rule 9.6.14, the Company announces that Peter Grant, Chief Executive Officer of Skyepharma PLC, was appointed in June 2014 as a non-executive director of Abzena Limited, which has since become Abzena plc. Abzena plc has today been listed on the AIM market of the London Stock Exchange.
10 July 2014
For further information, please contact:
Skyepharma PLC
John Murphy
Group Counsel and Company Secretary +44 20 7881 0524
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
SKP.L